State of Wisconsin Investment Board
SYRS

State of Wisconsin Investment Board’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

State of Wisconsin Investment Board’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,975
Closed -$267K – 2226
2021
Q3 		$267K Hold
5,975
– – ﹤0.01% 2005
2021
Q2 		$326K Sell
5,975
-2,370
-28% -$140K ﹤0.01% 1889
2021
Q1 		$624K Sell
8,345
-630
-7% -$65.5K ﹤0.01% 1513
2020
Q4 		$974K Sell
8,975
-820
-8% -$74.8K ﹤0.01% 1337
2020
Q3 		$866K Buy
9,795
+4,445
+83% +$505K ﹤0.01% 1324
2020
Q2 		$570K Sell
5,350
-1,320
-20% -$118K ﹤0.01% 1387
2020
Q1 		$396K Buy
6,670
+1,470
+28% +$99.7K ﹤0.01% 1410
2019
Q4 		$359K Hold
5,200
– – ﹤0.01% 1516
2019
Q3 		$540K Buy
5,200
+1,680
+48% +$159K ﹤0.01% 1295
2019
Q2 		$326K Buy
3,520
+80
+2% +$5.57K ﹤0.01% 1427
2019
Q1 		$314K Buy
3,440
+780
+29% +$54.3K ﹤0.01% 1418
2018
Q4 		$148K Buy
2,660
+90
+4% +$6.84K ﹤0.01% 1473
2018
Q3 		$306K Buy
+2,570
New +$298K ﹤0.01% 1464

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State of Wisconsin Investment Board's SYRS Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2021, closing a stake of 5,975 shares — an estimated $267K sold.

State of Wisconsin Investment Board first reported a position in SYRS in Q3 2018 and held it in 13 quarters. The position peaked at $974K in Q4 2020. 90 funds tracked by Wall St. Rank hold SYRS as of Q4 2021.

  • State of Wisconsin Investment Board reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 5,975 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $267K.
  • State of Wisconsin Investment Board first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Syros Pharmaceuticals, Inc. Common Stock position peaked at $974K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.